Yohei Kawaguchi

Dr. Yohei Kawaguchi

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 April 2023 in Children
Verified
Journal Article
Open access
PDF file
HAHisaki Aiba
Hisaki Aiba
MKMichi Kamei
Michi Kamei
YIYasuhiko Ito
Yasuhiko Ito
RTRisa Takeda
Risa Takeda
SYSatoshi Yamada
Satoshi Yamada
HKHiroaki Kimura
Hiroaki Kimura
For the treatment of osteosarcoma, cisplatin (CDDP) can be substituted by carboplatin (CBDCA) to reduce toxicity. We report a single institution experience of CBDCA-based regimen. Two to three cycles of CBDCA + ifosfamide (IFO) therapy (window therapy) were administered as neoadjuvant therapy for osteosarcoma. Depending on the response of window therapy, the subsequent protocols were determined; for good responders, surgery is performed, and postoperative therapies with CBDCA + IFO, adriamycin (ADM) and high-dose methotrexate (MTX) were administered; for stable disease, the postoperative regimens were advanced before surgery, and the remaining amount of postoperative chemotherapy is deduced; for progressive disease, CBDCA-based regimen is changed to CDDP-based regimen. From 2009 to 2019, seven patients were treated with this protocol. During the window therapy, two patients (28.6%) were assessed as good responders and completed the regimen as planned. Four patients (57.1%) had stable disease, and the chemotherapy schedules were modified. One patient (14.2%) with progressive disease was shifted to the CDDP-based regimen. At final follow-up, four patients showed no evidence of disease and three patients died of the disease. Since the efficacy during window therapy was limited, a CBDCA-based regimen in the neoadjuvant setting was considered insufficient for performing adequate surgery.

8 June 2025 in European Journal of Orthopaedic Surgery & Traumatology
Verified
Journal Article
Closed access
PDF file
HIHidetoshi Iwata
Hidetoshi Iwata
GSGo Sakai
Go Sakai
YKYasuhiro Katsuda
Yasuhiro Katsuda
SFShinji Funahashi
Shinji Funahashi
JSJun Shibata
Jun Shibata
YKYohei Kawaguchi
Yohei Kawaguchi

1 January 2020 in Medicine
Verified
Journal Article
Open access
YKYohei Kawaguchi
Yohei Kawaguchi
HOHideki Okamoto
Hideki Okamoto
KEKojiro Endo
Kojiro Endo
HIHidetoshi Iwata
Hidetoshi Iwata
YJYuji Joyo
Yuji Joyo
HMHideki Murakami
Hideki Murakami
Introduction: Corynebacterium striatum is common contaminant in clinical specimens. Here, we report a rare case of pyogenic tenosynovitis of the wrist caused by C striatum in a dermatomyositis patient taking oral immunosuppressants. Patient concerns: A 67-year-old Japanese woman with dermatomyositis had a history of multiple intraarticular injections of corticosteroids to the right wrist joint for the treatment of osteoarthritis. She was admitted to our hospital with a painful lump on the right dorsal wrist lasting for three months. MRI revealed cellulitis of the dorsum of the right wrist and hand and fluid collection in the extensor tendon sheath. C striatum was detected in the cultures of three samples of synovial fluid taken from the dorsal hand. Diagnosis: Pyogenic tenosynovitis of the wrist due to C striatum. Interventions: The infection was successfully controlled with synovectomy and adjuvant antibiotic therapy. Outcomes: There has been no sign of recurrence for 12-months after the surgical treatment. Lessons: This is the first reported case of pyogenic tenosynovitis due to C striatum in a patient with dermatomyositis. Clinicians should be aware that patients undergoing immunosuppressive therapy have a risk of C striatum infection.